James R. Gruber, CFO of Eton Pharmaceuticals ($ETON), sold shares on the open market twice in the last year, for a total of nearly $674,000. His most recent sale was on August 20, 2025. These transactions rank 5,834th out of 11,678 individual insiders in our database, below the average sale value of 8.6 million across about 6.4 trades per seller. Gruber made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | Eton Pharmaceuticals, Inc. | $ETON | Gruber James R. | Chief Financial Officer | A | Restricted Stock Units | 25856 | $0.00 | 279,931.0000 | 26,893,000 | 10.18% | 0.10% |
| Jan. 12, 2026 | Eton Pharmaceuticals, Inc. | $ETON | Gruber James R. | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 40655 | $0.00 | 254,075.0000 | 26,893,000 | 19.05% | 0.15% |
| Jan. 14, 2026 | Eton Pharmaceuticals, Inc. | $ETON | Gruber James R. | Chief Financial Officer | F | Common Stock | 2293 | $15.47 | 213,420.0000 | 26,893,000 | 1.06% | 0.01% |
| Dec. 11, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Gruber James R. | Chief Financial Officer | A | Restricted Stock Units | 5502 | $0.00 | 210,255.0000 | 26,893,000 | 2.69% | 0.02% |
| Dec. 12, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Gruber James R. | Chief Financial Officer | F | Common Stock | 4542 | $16.99 | 215,713.0000 | 26,893,000 | 2.06% | 0.02% |
| Aug. 19, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Gruber James R. | Chief Financial Officer | S | Common Stock | 39082 | $16.16 | 205,299.0000 | 25,895,086 | 15.99% | 0.15% |
| Aug. 20, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Gruber James R. | Chief Financial Officer | S | Common Stock | 2631 | $16.02 | 204,753.0000 | 25,895,086 | 1.27% | 0.01% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Gruber James R. | Chief Financial Officer | A | Restricted Stock Units | 25876 | $0.00 | 25,876.0000 | 25,895,086 | 9999.99% | 0.10% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | Gruber James R. | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 38621 | $0.00 | 38,621.0000 | 25,895,086 | 9999.99% | 0.15% |
| Feb. 13, 2024 | Eton Pharmaceuticals, Inc. | $ETON | Gruber James R. | Chief Financial Officer | A | Stock Option (Right to buy) | 144677 | $0.00 | 374,763.0000 | 25,645,366 | 62.88% | 0.56% |
| March 3, 2023 | Eton Pharmaceuticals, Inc. | $ETON | Gruber James R. | Chief Financial Officer | A | Stock Option (right to buy) | 100086 | $0.00 | 200,086.0000 | 25,146,000 | 100.09% | 0.40% |